Covington has a leading food and drug practice recognized internationally for its breadth and depth of expertise. Our lawyers and professionals have been actively involved in all of the major legislative initiatives that have affected pharmaceutical regulation, beginning with its representation of the National Canners Association in 1919. The firm’s practice features two former Chief Counsels of the FDA and former key staff on health care congressional committees.
Public Policy and Government Affairs is a key component of the firm’s food and drug practice. The firm’s substantive and political experts have assisted clients with their policy concerns on a broad range of legislation, including the 1997 enactment of the Food and Drug Administration Modernization Act, the Orphan Drug Act, the Drug Price Competition and Patent Term Restoration Act, the FDA Export Reform and Enhancement Act of 1996, the Drug Export Amendments of 1986, the Prescription Drug User Fee Act, and the Medicare Modernization Act, among others. Our work on behalf of trade associations and individual companies has included drafting and negotiating bills and amendments, testifying before congressional committees, representing client witnesses before congressional committees, meeting with congressional staff and members, analyzing and summarizing legislative proposals, and preparing talking points and advocacy documents. Our vast substantive knowledge of FDA law and our wide experience in the industry, coupled with the legislative expertise of our Public Policy and Government Affairs practice group enable us to provide an integrated approach on legislative matters that is unmatched in the profession.